![The World Congress on Controversies in Obstetrics, Gynecology and Infertility (COGI). Click here to learn more.]({"type":"image" , "src" : "/sda/112382/JournalAd-COGI2024-Leaderboard.jpg"})
References
- Abu-Shawer, O., et al., 2019. Hematologic markers of distant metastases and poor prognosis in gynecological cancers. BMC Cancer, 19 (1), 1.
- Canadian Cancer Society’s Advisory Committee on Cancer Statistics 2016. Canadian Cancer Statistics. Toronto, ON: Canadian Cancer Society.
- Chen, H., et al., 2020. Nomograms based on the novel platelet index score predict postoperative prognosis in endometrial cancer. Gynecologic Oncology, 158 (3), 689–7.
- Crosby, D.A., et al., 2018. CA125 measured during menstruation can be misleading. Irish Medical Journal, 111 (4), 738.
- Cui, M.M., et al., 2017. Platelet distribution width correlates with prognosis of non-small cell lung cancer. Scientific Reports, 7 (1), 3456.
- Epiney, M., et al., 2000. CA125 production by the peritoneum: in-vitro and in-vivo studies. Human Reproduction , 15 (6), 1261–1265.
- Friis Petersen, J., et al., 2019. Early pregnancy reference intervals; 29 serum analytes from 4 to 12 weeks’ gestation in naturally conceived and uncomplicated pregnancies resulting in live births. Clinical Chemistry and Laboratory Medicine, 57 (12), 1956–1967.
- Fu, S., et al., 2018. Squamous cell carcinoma antigen, platelet distribution width, and prealbumin collectively as a marker of squamous cell cervical carcinoma. Cancer Biomarkers: section A of Disease Markers, 21 (2), 317–321.
- Grivennikov, S.I., et al., 2010. Immunity, inflammation, and cancer. Cell, 140 (6), 883–899.
- Kokot, I., et al., 2021. Diagnostic significance of selected serum inflammatory markers in women with advanced endometriosis. International Journal of Molecular Sciences, 22 (5), 2295.
- Kurtoglu, E., et al., 2015. Platelet indices may be useful in discrimination of benign and malign endometrial lesions, and early and advanced stage endometrial cancer. Asian Pacific Journal of Cancer Prevention, 16 (13), 5397–5400.
- Lee, Y.C., et al., 2017. Treatment strategies for endometrial cancer: current practice and perspective. Current Opinion in Obstetrics & Gynecology, 29 (1), 47–58.
- Matsubara, S., et al., 2021. Prognostic value of pre-treatment systemic immune-inflammation index in patients with endometrial cancer. PLOS One, 16 (5), e0248871.
- Modarres-Gilani, M., et al., 2017. The prognostic role of preoperative serum CA125 levels in patients with advanced endometrial carcinoma. Cancer Biomarkers: section A of Disease Markers, 20 (2), 135–141.
- Qin, C., et al., 2021. Predictive effects of preoperative serum CA125 and AFP levels on post-hepatectomy survival in patients with hepatitis B-related hepatocellular carcinoma. Oncology Letters, 21 (6), 487.
- Qin, L., et al., 2020. Higher platelet distribution width is associated with unfavorable prognosis in ovarian cancer. Cancer Biomarkers: section A of Disease Markers, 28 (3), 365–370.
- Reijnen, C., et al., 2019. Improved preoperative risk stratification with CA-125 in low-grade endometrial cancer: a multicenter prospective cohort study. Journal of Gynecologic Oncology, 30 (5), e70.
- Sung, H., et al., 2021. Global Cancer Statistics 2020: GLOBOCAN Estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: a Cancer Journal for Clinicians, 71 (3), 209–249.
- Vincent, L. and Rafii, S., 2004. Vascular frontiers without borders: multifaceted roles of platelet-derived growth factor (PDGF) in supporting postnatal angiogenesis and lymphangiogenesis. Cancer Cell, 6 (4), 307–309.
- Zhang, H., et al., 2020. Clinical application of red cell distribution width, mean platelet volume, and cancer antigen 125 detection in endometrial cancer. Journal of Clinical Laboratory Analysis, 34 (8), e23309.